These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 12941683)

  • 1. Psychopharmacological treatment of major depressive disorder in children and adolescents.
    Varley CK
    JAMA; 2003 Aug; 290(8):1091-3. PubMed ID: 12941683
    [No Abstract]   [Full Text] [Related]  

  • 2. Which SSRIs most effectively treat depression in adolescents?
    DeLucia V; Kelsberg G; Safranek S
    J Fam Pract; 2016 Sep; 65(9):632-4. PubMed ID: 27672691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant treatment strategy with an early onset of action improves the clinical outcome in patients with major depressive disorder and high anxiety: a multicenter and 6-week follow-up study.
    Liao XM; Su YA; Wang Y; Yu X; Si TM
    Chin Med J (Engl); 2020 Mar; 133(6):726-728. PubMed ID: 32097208
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder.
    Spielmans GI
    JAMA; 2004 Jan; 291(1):41. PubMed ID: 14709570
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder.
    Solyom AE
    JAMA; 2004 Jan; 291(1):41-2; author reply 42. PubMed ID: 14709569
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder.
    Price D
    JAMA; 2004 Jan; 291(1):40-1; author reply 42. PubMed ID: 14709568
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder.
    Mathews M; Mathews M; Mathews J
    JAMA; 2004 Jan; 291(1):40; author reply 42. PubMed ID: 14709567
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitor treatment of major depressive disorder in children and adolescents.
    Newcorn JH
    Curr Psychiatry Rep; 2004 Apr; 6(2):85-7. PubMed ID: 15038909
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.
    Brent DA
    Depress Anxiety; 2009; 26(10):871-4. PubMed ID: 19798756
    [No Abstract]   [Full Text] [Related]  

  • 10. Sertraline and depression in children.
    Garland EJ
    JAMA; 2004 Apr; 291(13):1561; author reply 1561-2. PubMed ID: 15069038
    [No Abstract]   [Full Text] [Related]  

  • 11. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is one selective serotonin reuptake inhibitor better than another?
    Elliott RL; Dane FC
    JAMA; 2002 Apr; 287(15):1935; author reply 1937-8. PubMed ID: 11960525
    [No Abstract]   [Full Text] [Related]  

  • 13. Is one selective serotonin reuptake inhibitor better than another?
    Stopa SF
    JAMA; 2002 Apr; 287(15):1935-6; author reply 1937-8. PubMed ID: 11960526
    [No Abstract]   [Full Text] [Related]  

  • 14. Is one selective serotonin reuptake inhibitor better than another?
    Culpepper L; Heeren T
    JAMA; 2002 Apr; 287(15):1936; author reply 1937-8. PubMed ID: 11960527
    [No Abstract]   [Full Text] [Related]  

  • 15. Is one selective serotonin reuptake inhibitor better than another?
    Keeley R
    JAMA; 2002 Apr; 287(15):1936-7; author reply 1937-8. PubMed ID: 11960528
    [No Abstract]   [Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
    Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
    Strawn JR; Mills JA; Croarkin PE
    J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
    [No Abstract]   [Full Text] [Related]  

  • 18. [A place for SSRIs in the treatment of severely depressed children and adolescents].
    Roobol TH; Buitelaar JK
    Ned Tijdschr Geneeskd; 2008 Aug; 152(31):1710-2. PubMed ID: 18727599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of sertraline vs. fluoxetine in patients age 70 or over with major depression.
    Finkel SI; Richter EM; Clary CM; Batzar E
    Am J Geriatr Psychiatry; 1999; 7(3):221-7. PubMed ID: 10438693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are paroxetine, fluoxetine, and sertraline equally effective for depression?
    Straton JB; Cronholm P
    J Fam Pract; 2002 Mar; 51(3):285. PubMed ID: 11978244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.